Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Vaccines

Free Subscription 07.05.2008 6 Clin Infect Dis 1 J Infect 32 J Infect Dis 2 J Virol 1 Lancet 2 MMWR Morb Mortal Wkly Rep 3 Pediatrics 1 Science 15 Vaccine 2 Virology 1 Virus Res

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Clin Infect Dis

1. COOPER CL , Angel JB, Seguin I, Davis HL, et al
   CPG 7909 adjuvant plus hepatitis B virus vaccination in HIV-infected adults achieves long-term seroprotection for up to 5 years.
   Clin Infect Dis. 2008;46:1310-4.
   PubMed     Related articles    Abstract available
   
   
2. CORTESE MM , Jordan HT, Curns AT, Quinlan PA, et al
   Mumps vaccine performance among university students during a mumps outbreak.
   Clin Infect Dis. 2008;46:1172-80.
   PubMed     Related articles    Abstract available
   
   
3. DE WALS P , Deceuninck G, Boucher RM, Ouakki M, et al
   Risk of Guillain-Barre syndrome following serogroup C meningococcal conjugate vaccine in Quebec, Canada.
   Clin Infect Dis. 2008;46:e75-7.
   PubMed     Related articles    Abstract available
   
   
4. RODRIGUEZ-BARRADAS MC , Goulet J, Brown S, Goetz MB, et al
   Impact of pneumococcal vaccination on the incidence of pneumonia by HIV infection status among patients enrolled in the Veterans Aging Cohort 5-Site Study.
   Clin Infect Dis. 2008;46:1093-100.
   PubMed     Related articles    Abstract available
   
   
5. WEINBERGER B , Herndler-Brandstetter D, Schwanninger A, Weiskopf D, et al
   Biology of immune responses to vaccines in elderly persons.
   Clin Infect Dis. 2008;46:1078-84.
   PubMed     Related articles    Abstract available
   
   
6. DE ROUX A , Schmoele-Thoma B, Siber GR, Hackell JG, et al
   Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.
   Clin Infect Dis. 2008;46:1015-23.
   PubMed     Related articles    Abstract available
   
   

   
   J Infect

7. LAU JT , Kim JH, Yang X, Tsui HY, et al
   Cross-sectional and longitudinal factors predicting influenza vaccination in Hong Kong Chinese elderly aged 65 and above.
   J Infect. 2008;.
   PubMed     Related articles    Abstract available
   
   

   
   J Infect Dis

8. SEWARD JF , Marin M, Vazquez M
   Varicella vaccine effectiveness in the US vaccination program: a review.
   J Infect Dis. 2008;197 Suppl 2:S82-9.
   PubMed     Related articles    Abstract available
   
   
9. LOPEZ AS , Kolasa MS, Seward JF
   Status of school entry requirements for varicella vaccination and vaccination coverage 11 years after implementation of the varicella vaccination program.
   J Infect Dis. 2008;197 Suppl 2:S76-81.
   PubMed     Related articles    Abstract available
   
   
10. CARBAJAL T , Civen R, Reynolds M, Chaves SS, et al
    Knowledge, attitudes, and practices regarding varicella vaccination among health care providers participating in the varicella active surveillance project, Antelope Valley, California, 2005.
    J Infect Dis. 2008;197 Suppl 2:S66-70.
    PubMed     Related articles    Abstract available
    
    
11. BREUER J , Schmid DS
    Vaccine oka variants and sequence variability in vaccine-related skin lesions.
    J Infect Dis. 2008;197 Suppl 2:S54-7.
    PubMed     Related articles    Abstract available
    
    
12. STORLIE J , Maresova L, Jackson W, Grose C, et al
    Comparative analyses of the 9 glycoprotein genes found in wild-type and vaccine strains of varicella-zoster virus.
    J Infect Dis. 2008;197 Suppl 2:S49-53.
    PubMed     Related articles    Abstract available
    
    
13. YAMANISHI K
    Molecular analysis of the Oka vaccine strain of varicella-zoster virus.
    J Infect Dis. 2008;197 Suppl 2:S45-8.
    PubMed     Related articles    Abstract available
    
    
14. TAKAHASHI M , Asano Y, Kamiya H, Baba K, et al
    Development of varicella vaccine.
    J Infect Dis. 2008;197 Suppl 2:S41-4.
    PubMed     Related articles    Abstract available
    
    
15. GERSHON AA , Arvin AM, Levin MJ, Seward JF, et al
    Varicella vaccine in the United States: a decade of prevention and the way forward.
    J Infect Dis. 2008;197 Suppl 2:S39-40.
    PubMed     Related articles   
    
    
16. GERSHON AA , Katz SL
    Perspective on live varicella vaccine.
    J Infect Dis. 2008;197 Suppl 2:S242-5.
    PubMed     Related articles    Abstract available
    
    
17. COHEN JI
    Strategies for herpes zoster vaccination of immunocompromised patients.
    J Infect Dis. 2008;197 Suppl 2:S237-41.
    PubMed     Related articles    Abstract available
    
    
18. OXMAN MN , Levin MJ
    Vaccination against Herpes Zoster and Postherpetic Neuralgia.
    J Infect Dis. 2008;197 Suppl 2:S228-36.
    PubMed     Related articles    Abstract available
    
    
19. REYNOLDS MA , Chaves SS, Harpaz R, Lopez AS, et al
    The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.
    J Infect Dis. 2008;197 Suppl 2:S224-7.
    PubMed     Related articles    Abstract available
    
    
20. HURLEY LP , Harpaz R, Daley MF, Crane LA, et al
    National survey of primary care physicians regarding herpes zoster and the herpes zoster vaccine.
    J Infect Dis. 2008;197 Suppl 2:S216-23.
    PubMed     Related articles    Abstract available
    
    
21. SCHMADER K , Gnann JW Jr, Watson CP
    The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine.
    J Infect Dis. 2008;197 Suppl 2:S207-15.
    PubMed     Related articles    Abstract available
    
    
22. LEVIN MJ
    Varicella vaccination of immunocompromised children.
    J Infect Dis. 2008;197 Suppl 2:S200-6.
    PubMed     Related articles    Abstract available
    
    
23. HAMBLETON S , Steinberg SP, Larussa PS, Shapiro ED, et al
    Risk of herpes zoster in adults immunized with varicella vaccine.
    J Infect Dis. 2008;197 Suppl 2:S196-9.
    PubMed     Related articles    Abstract available
    
    
24. MACARTNEY KK , Burgess MA
    Varicella vaccination in Australia and New Zealand.
    J Infect Dis. 2008;197 Suppl 2:S191-5.
    PubMed     Related articles    Abstract available
    
    
25. SADZOT-DELVAUX C , Rentier B, Wutzler P, Asano Y, et al
    Varicella vaccination in Japan, South Korea, and Europe.
    J Infect Dis. 2008;197 Suppl 2:S185-90.
    PubMed     Related articles    Abstract available
    
    
26. WILSON E , Goss MA, Marin M, Shields KE, et al
    Varicella vaccine exposure during pregnancy: data from 10 Years of the pregnancy registry.
    J Infect Dis. 2008;197 Suppl 2:S178-84.
    PubMed     Related articles    Abstract available
    
    
27. CHAVES SS , Haber P, Walton K, Wise RP, et al
    Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005.
    J Infect Dis. 2008;197 Suppl 2:S170-7.
    PubMed     Related articles    Abstract available
    
    
28. GALEA SA , Sweet A, Beninger P, Steinberg SP, et al
    The safety profile of varicella vaccine: a 10-year review.
    J Infect Dis. 2008;197 Suppl 2:S165-9.
    PubMed     Related articles    Abstract available
    
    
29. ZHOU F , Ortega-Sanchez IR, Guris D, Shefer A, et al
    An economic analysis of the universal varicella vaccination program in the United States.
    J Infect Dis. 2008;197 Suppl 2:S156-64.
    PubMed     Related articles    Abstract available
    
    
30. SHINEFIELD HR , Black S, Kuter BJ
    Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
    J Infect Dis. 2008;197 Suppl 2:S152-5.
    PubMed     Related articles    Abstract available
    
    
31. BREUER J , Schmid DS, Gershon AA
    Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
    J Infect Dis. 2008;197 Suppl 2:S147-51.
    PubMed     Related articles    Abstract available
    
    
32. WATSON B
    Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
    J Infect Dis. 2008;197 Suppl 2:S143-6.
    PubMed     Related articles    Abstract available
    
    
33. BLACK S , Ray P, Shinefield H, Saddier P, et al
    Lack of association between age at varicella vaccination and risk of breakthrough varicella, within the Northern California Kaiser Permanente Medical Care Program.
    J Infect Dis. 2008;197 Suppl 2:S139-42.
    PubMed     Related articles    Abstract available
    
    
34. CHAVES SS , Zhang J, Civen R, Watson BM, et al
    Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005.
    J Infect Dis. 2008;197 Suppl 2:S127-31.
    PubMed     Related articles    Abstract available
    
    
35. PARKER AA , Reynolds MA, Leung J, Anderson M, et al
    Challenges to implementing second-dose varicella vaccination during an outbreak in the absence of a routine 2-dose vaccination requirement--Maine, 2006.
    J Infect Dis. 2008;197 Suppl 2:S101-7.
    PubMed     Related articles    Abstract available
    
    
36. GO V , Pollard RB
    A Cytomegalovirus Vaccine for Transplantation: Are We Closer?
    J Infect Dis. 2008;.
    PubMed     Related articles   
    
    
37. WLOCH MK , Smith LR, Boutsaboualoy S, Reyes L, et al
    Safety and Immunogenicity of a Bivalent Cytomegalovirus DNA Vaccine in Healthy Adult Subjects.
    J Infect Dis. 2008;.
    PubMed     Related articles    Abstract available
    
    
38. HALASA NB , Gerber MA, Chen Q, Wright PF, et al
    Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccine in Infants.
    J Infect Dis. 2008;197:1448-1454.
    PubMed     Related articles    Abstract available
    
    
39. LU CY , Ni YH, Chiang BL, Chen PJ, et al
    Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization.
    J Infect Dis. 2008;197:1419-26.
    PubMed     Related articles    Abstract available
    
    

    
    J Virol

40. BANSAL A , Jackson B, West K, Wang S, et al
    Multifunctional T cell characteristics induced by a polyvalent DNA prime/protein boost HIV-1 vaccine regimen given to healthy adults are dependant upon the route and dose of administration.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
41. KAUFMAN DR , Goudsmit J, Holterman L, Ewald BA, et al
    Differential Antigen Requirements for Protection Against Systemic and Intranasal Vaccinia Virus Challenges in Mice.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    

    
    Lancet

42. EHRENFELD E , Glass RI, Agol VI, Chumakov K, et al
    Immunisation against poliomyelitis: moving forward.
    Lancet. 2008;371:1385-7.
    PubMed     Related articles   
    
    

    
    MMWR Morb Mortal Wkly Rep

43. 
    Report from the Advisory Committee on Immunization Practices (ACIP): decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal conjugate vaccine (MCV4).
    MMWR Morb Mortal Wkly Rep. 2008;57:462-5.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
44. 
    Syncope after vaccination--United States, January 2005-July 2007.
    MMWR Morb Mortal Wkly Rep. 2008;57:457-60.
    PubMed     Related articles    Abstract available   Free Full Text
    
    

    
    Pediatrics

45. TATE JE , Simonsen L, Viboud C, Steiner C, et al
    Trends in Intussusception Hospitalizations Among US Infants, 1993-2004: Implications for Monitoring the Safety of the New Rotavirus Vaccination Program.
    Pediatrics. 2008;121:e1125-32.
    PubMed     Related articles    Abstract available
    
    
46. OVSYANNIKOVA IG , Jacobson RM, Dhiman N, Vierkant RA, et al
    Human leukocyte antigen and cytokine receptor gene polymorphisms associated with heterogeneous immune responses to mumps viral vaccine.
    Pediatrics. 2008;121:e1091-9.
    PubMed     Related articles    Abstract available
    
    
47. 
    Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.
    Pediatrics. 2008;121:e1016-31.
    PubMed     Related articles    Abstract available
    
    

    
    Science

48. RUSSELL CA , Jones TC, Barr IG, Cox NJ, et al
    The global circulation of seasonal influenza A (H3N2) viruses.
    Science. 2008;320:340-6.
    PubMed     Related articles    Abstract available
    
    

    
    Vaccine

49. BHATLA N , Lal N, Bao YP, Ng T, et al
    A meta-analysis of human papillomavirus type-distribution in women from South Asia: Implications for vaccination.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
50. GRAY K , Legg K, Sharp A, Mackie N, et al
    Participation in two phase II prophylactic HIV vaccine trials in the UK.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
51. LUND V , Mikkelsen H, Schroder MB
    Comparison of atypical furunculosis vaccines in spotted wolffish (Anarhicas minor O.) and Atlantic halibut (Hippoglossus hippoglossus L.).
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
52. CHEN HL , Huang JY, Chu TW, Tsai TC, et al
    Expression of VP1 protein in the milk of transgenic mice: A potential oral vaccine protects against enterovirus 71 infection.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
53. BRAVE A , Hallengard D, Schroder U, Blomberg P, et al
    Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
54. DRAGHIA-AKLI R , Khan AS, Brown PA, Pope MA, et al
    Parameters for DNA vaccination using adaptive constant-current electroporation in mouse and pig models.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
55. MASSAD E , Struchiner CJ, Burattini MN, Coutinho FA, et al
    An optimal vaccination strategy against rotavirus.
    Vaccine. 2008;.
    PubMed     Related articles   
    
    
56. LYONS A , Longfield J, Kuschner R, Straight T, et al
    A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
57. NORTON SP , Scheifele DW, Bettinger JA, West RM, et al
    Influenza vaccination in paediatric nurses: Cross-sectional study of coverage, refusal, and factors in acceptance.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
58. GREENWOOD DL , Dynon K, Kalkanidis M, Xiang S, et al
    Vaccination against foot-and-mouth disease virus using peptides conjugated to nano-beads.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
59. DU N , Li W, Li Y, Liu S, et al
    Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
60. MORALES J , Martinez JJ, Manoutcharian K, Hernandez M, et al
    Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
61. JAOKO W , Nakwagala FN, Anzala O, Manyonyi GO, et al
    Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
62. SHOJI Y , Chichester JA, Bi H, Musiychuk K, et al
    Plant-expressed HA as a seasonal influenza vaccine candidate.
    Vaccine. 2008;.
    PubMed     Related articles    Abstract available
    
    
63. CHAN SS
    Influenza vaccination for healthcare workers: Is it really as effective as we claim?
    Vaccine. 2008;.
    PubMed     Related articles   
    
    

    
    Virology

64. ZOLLA-PAZNER S , Cohen SS, Krachmarov C, Wang S, et al
    Focusing the immune response on the V3 loop, a neutralizing epitope of the HIV-1 gp120 envelope.
    Virology. 2007;.
    PubMed     Related articles    Abstract available
    
    
65. WYATT LS , Belyakov IM, Earl PL, Berzofsky JA, et al
    Enhanced cell surface expression, immunogenicity and genetic stability resulting from a spontaneous truncation of HIV Env expressed by a recombinant MVA.
    Virology. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    

    
    Virus Res

66. DAMIANI AM , Scicluna MT, Ciabatti I, Cardeti G, et al
    Genetic characterization of equine influenza viruses isolated in Italy between 1999 and 2005.
    Virus Res. 2007;.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: